Effect of intraoperative sufentanil use on postoperative pain in patients undergoing ambulatory surgery under general anesthesia

Effect of intraoperative sufentanil use on postoperative pain in patients undergoing ambulatory surgery under general anesthesia - Sopas

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000055547

Enrollment

Registered

2024-12-15

Start date

2024-09-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraoperative sufentanil , ambulatory surgery

Interventions

Sufentanil Remifentanil

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adult patients aged 19 years and older undergoing surgery under general anesthesia through the ambulatory surgery center on the day of surgery

Exclusion criteria

Exclusion criteria: Preexisting renal or hepatic dysfunction Pregnant women Patients with known drug hypersensitivity to propofol, remifentanil, or sufentanil

Design outcomes

Primary

Measure	Time frame
The total dose of fentanyl administered (in micrograms) for postoperative analgesia.	—

Secondary

Measure	Time frame
Number of doses of analgesics administered for postoperative pain relief Occurrence of nausea and vomiting postsurgery, and use of antiemetics Postoperative shivering Time from administration of reversal agent to extubation Recovery room stay duration Time spent in the surgery center on the day of surgery Patient satisfaction with anesthesia management at discharge from the surgery center	—

Countries

Asia(except Japan)

Contacts

Public ContactJiyoun Lee

Seoul National University Bundang Hospital Anesthesia and Pain Medicine

heykiki1@hanmail.net0317873640

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026